Format

Send to

Choose Destination

See 1 citation found by title matching your search:

Curr Opin Chem Biol. 2017 Jun;38:45-51. doi: 10.1016/j.cbpa.2017.02.004. Epub 2017 Apr 20.

Protein epitope mimetic macrocycles as biopharmaceuticals.

Author information

1
Polyphor Ltd, Hegenheimermattweg 125, 4123 Allschwil, Switzerland.
2
Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
3
Polyphor Ltd, Hegenheimermattweg 125, 4123 Allschwil, Switzerland. Electronic address: daniel.obrecht@polyphor.com.

Abstract

Fully synthetic medium-sized macrocyclic peptides mimicking the key β-hairpin and α-helical protein epitopes relevant in many protein-protein interactions have emerged as a novel class of drugs with the potential to fill an important gap between small molecules and proteins. Conformationally stabilized macrocyclic scaffolds represent ideal templates for medicinal chemists to incorporate bioactive peptide and protein pharmacophores in order to generate novel drugs to treat diseases with high unmet medical need. This review describes recent approaches to design and generate large libraries of such macrocycles, for hit identification, and for their efficient optimization. Finally, this review describes some of the most advanced protein epitope mimetic (PEM) macrocycles in clinical development.

PMID:
28319811
DOI:
10.1016/j.cbpa.2017.02.004
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center